A first-in-human study to investigate safety and tolerability of SAR446959 in participants with osteoarthritis of the knee
SAD18258
Phase 1 other active
Quick answer
A first-in-human study to investigate safety and tolerability of SAR446959 in participants with osteoarthritis of the knee for Osteoarthritis is a Phase 1 program (other) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- Osteoarthritis
- Phase
- Phase 1
- Modality
- other
- Status
- active